Rapport Therapeutics, Inc.

Siren, L.L.C. RAPP
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/14/2026
Shares
641,469
Value ($000)
20,072
Weight
0.6%
2024 Q3 - 2026 Q1 (7 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).